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Vitamin E inhibits the UVAI
induction of “light” and “dark”
cyclobutane pyrimidine dimers,
and oxidatively generated DNA
damage, in keratinocytes
George J. Delinasios1,5, Mahsa Karbaschi2,4, Marcus S. Cooke

2,3,4

& Antony R. Young1

Solar ultraviolet radiation (UVR)-induced DNA damage has acute, and long-term adverse effects
in the skin. This damage arises directly by absorption of UVR, and indirectly via photosensitization
reactions. The aim of the present study was to assess the effects of vitamin E on UVAI-induced DNA
damage in keratinocytes in vitro. Incubation with vitamin E before UVAI exposure decreased the
formation of oxidized purines (with a decrease in intracellular oxidizing species), and cyclobutane
pyrimidine dimers (CPD). A possible sunscreening effect was excluded when similar results were
obtained following vitamin E addition after UVAI exposure. Our data showed that DNA damage by
UVA-induced photosensitization reactions can be inhibited by the introduction of vitamin E either preor post-irradiation, for both oxidized purines and CPD (including so-called “dark” CPDs). These data
validate the evidence that some CPD are induced by UVAI initially via photosensitization, and some
via chemoexcitation, and support the evidence that vitamin E can intervene in this pathway to prevent
CPD formation in keratinocytes. We propose the inclusion of similar agents into topical sunscreens and
aftersun preparations which, for the latter in particular, represents a means to mitigate on-going DNA
damage formation, even after sun exposure has ended.
The short- and long-term consequences of solar UVR (~295–400 nm) exposure are well-established1 but detailed
knowledge of the, spectral effects and mechanisms, especially long-term effects, is lacking. The majority (>95%)
of solar UVR is UVA, most of which (~75%) is UVAI (340–400 nm). This spectral region penetrates the skin
deeper that UVB (280–320 nm), readily reaching the dermal collagen and elastic fibres2.
The mutagenicity of UVA is caused through induction of DNA damage via direct absorption of UVR by
DNA, and indirectly via photosensitization reactions3,4. This mutagenicity has been attributed, at least in part,
to oxidatively generated modification of DNA nucleobases5. One of the most intensively studied lesions is the
oxidatively modified purine, 8-oxo-7,8-dihydroguanine (8-oxoGua). This lesion is a possible contributor to UVA
mutagenesis, and its presence has been studied in both epidermal DNA and urine6–8. It has also been proposed
that UVA may increase intracellular oxidative stress without the generation of additional reactive oxygen species
(ROS), by increasing the ratio of GSSG/GSH9. Cyclobutane pyrimidine dimers (CPDs) are DNA photolesions that
have important biological consequences, including mutagenicity, which may lead to keratinocyte cancers of the
skin10. CPDs also have non-mutagenic consequences such as initiating cytokine release11, and photoimmunosuppression that are also thought to be involved in skin cancer12. Importantly, a recent report has demonstrated that
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Treatment

Viable cells (%) TB

Viable cells (%) MTT

Control*

87.3 ± 3.2

88.7 ± 2.5

20 J/cm2 UVAI*

81.8 ± 4.3

80.1 ± 3.6

Vitamin E

88.6 ± 2.5

89.2 ± 2.0

20 J/cm2 UVA + Vitamin E 85.9 ± 1.6

86.5 ± 2.5

Table 1. HaCaT cell viability following UVA ± vit E. Cell viability was assessed by the trypan blue (TB)
exclusion and the MTT assays. Data represent the mean of three independent experiments ± SEM. One-way
ANOVA with Bonferroni correction showed significant differences between all groups (p < 0.05). *Cells
incubated with EtOH for 24 h.

UVA exposure of melanin can trigger the formation of CPD via chemically generated, excited electronic states.
The resulting so-called “dark” CPD, can continue to be formed for at least 3 h after UVA exposure13, in contrast to
CPD formed immediately upon irradiation (now considered “light” CPD). This phenomenon has been demonstrated previously in melanocytes, and melanosome recipient keratinocytes in vivo, but not human keratinocytes.
The increasing incidence of skin cancer in sun-sensitive, white-skinned populations has initiated great debate
on acute and long-term photoprotection. Sunscreens have limitations14 and consequently other methods of photoprotection are being sought. These include the use of various antioxidant substances, although it has often been
difficult to prove their efficacy for protection of human skin in vivo.
α-Tocopherol (vitamin E) is a well-known antioxidant that is believed to be the most important naturally
occurring non-enzymatic, lipid-soluble antioxidant in human tissue. Vitamin E can scavenge UVA-induced free
radicals, protect endogenous epidermal antioxidant degradation and prevent lipid peroxidation, as well as inhibit
UVR-induced immunosuppression15–17. Vitamin E has been employed in combination with vitamin C revealing
significant protection against sunburn and erythema, indicating potential protection against skin cancer and
photoageing18,19. Apart from its free radical scavenging properties, the application of vitamin E prior to UVR
exposure has attracted attention for its ability to prevent the formation of UVB-induced CPD20. This property has
been reported in mouse skin in vivo (samples were obtained immediately after UVR), however it is unclear as to
whether this should be attributed to a sunscreen effect or some other activity of vitamin E21–23, the precise nature
of which is unclear.
Despite the generally accepted beneficial effects of vitamin E, its photoprotective properties, especially on
human skin cells, against UVA and UVB irradiation have not been clearly established. The current study was
undertaken in order to determine the potential for vitamin E to protect against UVAI-induced photolesions, with
particular emphasis on dark CPDs, in keratinocytes.

Results

Pre-UVAI treatment with vitamin E protects against oxidizing species and DNA damage. Cell
viability was found to be unaffected by UVAI exposure and/or vitamin E treatment (Table 1). A UVA dose-dependent increase in oxidizing species, determined by H2DCFDA fluorescence, was observed (Fig. 1A). Pre-UVAI
treatment with vitamin E was found to offer significant protection at all UVAI doses tested. This was demonstrated at all cases (p < 0.05), with the effect being more evident at higher UVAI doses. The effect was highly significant at 40 J/cm2 with a 35% decrease in oxidizing species compared to control (p < 0.001). Vitamin E did not
alter the level of intracellular oxidizing species in unirradiated cells. Incubating HaCaTs with vitamin E for 24 h,
prior to irradiation, significantly increased intracellular GSH levels by 2.3-fold (p = 0.002), and protected against
UVAI-induced GSH depletion (Fig. 1B), suggesting that the UVAI-induced oxidizing species detected above are,
at least in part, ROS.
Comet analysis in the absence of any enzyme treatment assesses alkali labile sites (ALS) and frank strand
breaks (SB). Throughout, the comet assay data for oxidized purines and CPD formation were corrected for
the levels of ALS and SB (ALS/SB background values were subtracted from the corresponding hOGG1- and
T4endoV-derived values). A UVAI dose-dependent increase in both oxidized purines and CPD formation was
demonstrated (Fig. 2). Pre-irradiation treatment of HaCaTs with vitamin E offered a statistically significant protection against UVAI-induced oxidized purines. This effect was observed at both UVAI doses tested (5 and 10 J/
cm2), and was more evident at 5 J/cm2 (66% decrease; p < 0.001). Interestingly, pre-UVA vitamin E treatment was
found to also inhibit UVAI-induced CPD formation, at both UVAI doses tested (60% and 23% decrease at 5 and
10 J/cm2, with p < 0.001 and p < 0.01, respectively).
Post-UVAI treatment with vitamin E protects against oxidizing species and DNA damage.

A
time-course study showed that all DNA lesions increased after UVAI exposure (0 h) with a peak of formation at
1 h (Fig. 3). This was partly expected for oxidized purines and ALS/SB, due to their formation by reactive intermediates, but was surprising for CPD. This reveals the delayed induction of dark CPD in keratinocytes, even after
removal from UVAI exposure (dotted line), and then their repair, contrasting with the expected repair of CPD
(dashed line; Fig. 3). The increase and decrease in CPD levels during the 0–2.5 h period was the basis for determining the time for the post-UVA vitamin E incubations in subsequent studies (i.e. Figs 4 and 5).
Cells treated with vitamin E exhibited lower levels of oxidizing species compared to their untreated counterparts (Fig. 4). This clear protective effect of vitamin E was found to be greater following doses of 20 and 40 J/
cm2 (maximal inhibition of the production of oxidizing species was 38%, at 40 J/cm2; p < 0.05). The post-UVA
protective effect of vitamin E was also evident on DNA damage. Vitamin E treatment significantly decreased the
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Figure 1. (A) UVAI-induced oxidizing species dose-response in: control (EtOH) or vitamin E (+Vit E) pretreated groups; cells were treated with vitamin E for 24 h followed by UVAI irradiation. The production of
oxidising species was determined by H2DCFDA fluorescence, coupled with flow cytometry. Results represent
the mean of three independent experiments ±SEM. The UVAI dose-responses were determined by linear
regression analyses. R2 was >0.98 and slopes were very significantly different from zero (p < 0.0001). (B) Effect
of vitamin E supplementation on intracellular HaCaT GSH levels. HaCaTs were supplemented with vitamin E
for 24 h prior to UVAI irradiation. Data are expressed as the means ± SEM of three independent experiments.
**p < 0.01.
formation of oxidized purines, compared to non-treated cells (70% and 32% decreases at 5 and 10 J/cm2, with
p < 0.001 and p < 0.01, respectively) (Fig. 5). Post-UVA vitamin E treatment was also found to decrease CPD
formation, an observation that cannot be attributed to a possible sunscreen property, since vitamin E was added
after UVA exposure. CPD values were decreased at both UVA doses tested (52% and 44% decrease at 5 and 10 J/
cm2, with p < 0.05 and p < 0.01, respectively). Induced DNA damage was lower in the post-UVAI incubation
control experiments compared to incubation pre-UVAI, especially at 5 J/cm2. This suggests DNA repair occurs
within 2.5 h of exposure.

Vitamin E prevents UVC-induced formation of oxidized purines, but not CPD. Monochromatic
UVC (254 nm) was employed to assess a possible sunscreening role of vitamin E (see discussion section for
fuller rationale). As expected; UVC induced high CPD levels, together with some oxidized purines, ALS and SB.
Incubation with vitamin E pre-UVC led to a significant decrease (Fig. 6) in ALS and SB and oxidized purines
(66%, p < 0.05) but had no effect on CPD formation.

Discussion

UVAI is by far the major spectral component of solar UVR and penetrates deeper into the skin than UVB. A
study of DNA damage depth profiles in human skin in vivo shows attenuation of CPD and pyrimidine (6–4)
pyrimidone photoproduct formation with increasing with skin (epidermis and dermis) depth, but the reverse is
true, for CPD at least, with UVAI24. This results in greater sensitivity of the keratinocyte stem cell and melanocyte
containing basal layer to UVAI exposure. UVA-induced mutations are more prevalent in the basal layer than the
supra-basal layers25. It is therefore important to find new strategies to protect the skin, especially the basal layer,
from UVAI-induced DNA damage. Vitamin E has been established as a UVR-induced ROS scavenger. To the
best of our knowledge, we provide the first evidence that UVAI-induced CPD (including dark CPD), as well as
oxidatively-generated DNA lesions, can be inhibited by vitamin E in HaCaT keratinocytes. Whilst the latter is in
line with its classical role as an antioxidant, the former is an important finding, given earlier, similar findings, but
Scientific REPOrTS | (2018) 8:423 | DOI:10.1038/s41598-017-18924-4
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Figure 2. Effect of pre-UVAI incubation with vitamin E on the formation of oxidized purines and CPD. Mean
percentage of tail DNA was determined following UVAI doses of 5 and 10 J/cm2. Results are the mean ± SEM of
three independent experiments; ***p < 0.001, **p < 0.01 for selected comparisons.

Figure 3. Induction and repair of UVAI-induced oxidized purines and CPDs, determined by the T4endoVand hOGG1-modified comet assay. HaCaT keratinocytes were irradiated with 5 J/cm2 UVA and were left to
repair for different time periods. At 0 h, the dotted line mainly represents the formation of “light” CPD. The
subsequent increase, with a peak at 1 h, represents the formation of “dark” CPD and their repair (1–2.5 h). The
dashed line, which joins the dotted line, represents the proposed, differential repair of “light” CPD. The results
are the mean ± SEM of three independent experiments.

in melanocytes13. Our UVAI doses (5 and 10 J/cm2) were sub-erythemal and physiologically and environmentally
relevant; a minimal erythema dose (MED) of UVAI is about 50 J/cm2 in fair skin types26.
Carboxy-H2DCFDA was selected to study the formation of oxidizing species because it can be oxidized by
several UVA-induced reactive oxygen species and free radicals (including H2O2, NO and peroxides)27. The data
showed a UVAI dose-dependent increase in oxidizing species formation in HaCaT cells. Cells treated with vitamin E, prior to UVA, produced less oxidizing species compared to controls at all tested doses. Under these same
conditions, levels of intracellular GSH increased, and subsequently provided some protection against the UVAI
induction of oxidizing species suggesting that at least some of these oxidizing species are ROS.
Interestingly, a protective effect was also seen when vitamin E was administered post-UVA. It is noteworthy
that more oxidizing species were generated post- versus pre-UVA incubation. This observation may be attributed
to the formation of oxidizing species via secondary biochemical pathways28. These species can result from lipid
peroxidation (which can be inhibited by vitamin E), which in turn might initiate the formation of further oxidatively damaged DNA.
The hOGG1-modified comet assay showed that UVAI induced the formation of oxidized purines in
a dose-dependent manner. Vitamin E offered a significant protective effect with pre- and post-exposure
incubation. Since the UVA-induced oxidation of purines are formed indirectly, predominantly via the

Scientific REPOrTS | (2018) 8:423 | DOI:10.1038/s41598-017-18924-4

4

www.nature.com/scientificreports/

Figure 4. UVAI-induced oxidizing species dose-response in: control (EtOH) or vitamin E (+Vit E) treated
groups; cells were treated with vitamin E for 2.5 h, after UVA irradiation. Production of oxidising species was
determined by H2DCFDA fluorescence. Results represent the mean of three independent experiments ± SEM.
The UVA dose-responses were determined by linear regression analyses. R2 was >0.92 and slopes were very
significantly different from zero (p < 0.0001).

Figure 5. Effects of post-UVAI incubation on oxidized purine and CPD formation. Mean percentage of tail
DNA was determined following UVA doses of 5 and 10 J/cm2 and treatment of cells with vitamin E for 2.5 h.
Results are the mean ± SEM of three independent experiments; ***p < 0.001, **p < 0.01, *p < 0.05 for selected
comparisons.
photosensitizer-dependent induction of 1O229,30, the antioxidant/scavenging properties of vitamin E were not
surprising, although this protective effect has not previously been demonstrated for oxidized purines by the
comet assay, especially with post-UVAI incubation. This suggests that, after the initial ROS generation via photochemical processes (energy transfer to molecular oxygen, electron abstraction, etc), biochemical pathways are
then responsible for the generation of secondary ROS, possibly through 1O2 production31,32. This may occur via
UVA-induced enzyme activity, e.g. activation of NADPH oxidase28. NADPH oxidase increases UVA-induced
superoxide, in mouse, monkey and human cell lines33, which can be converted to other ROS. Other studies show
evidence of a protective effect of vitamin E against ovulation-induced 8-oxoGua in ovarian epithelial cells 34,
as well as ozone-induced 8-oxoGua35. The antioxidant role of vitamin E has been reported to protect against
cis-urocanic acid-induced ROS36. It is worth noting that 1O2 does not generate strand breaks, although some
alkali-labile sites (both of which may be evaluated by the comet assay) can be produced (as noted in Cooke et al.37,
but predominantly it is the nucleobase modification, 8-oxoGua, that is generated38.
CPDs, assessed by the T4endoV-modified comet assay, were readily induced by UVAI irradiation, and their
formation was significantly inhibited by incubation with vitamin E before and after irradiation. The ability of
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Figure 6. Effect of vitamin E pre-incubation on UVC-induced formation of CPD and oxidized purines,
determined by T4endoV- and hOGG1-modified comet assays, respectively. The results represent mean (±SEM)
percentage tail DNA in HaCaT cells exposed to UVC for 10 s, and have been corrected for baseline levels of
damage and SB/ALS. Results are the mean ± SEM of three independent experiments; *p < 0.05 for selected
comparisons.

Figure 7. Emission spectrum of the “UVA spot”. This was determined by a Bentham DM150 double
monochromator spectroradiometer through the plastic lid of a petri dish in which cells were irradiated, at a
distance of 39 cm. Also shown is the absorption spectrum of a vitamin E solution (0.1 mg/mL in ethanol).
post-UVAI vitamin E incubation to inhibit CPD excludes a sunscreening effect, but also alludes to an indirect
mechanism for UVAI-induced CPD. This is supported by the irradiation studies with UVC (254 nm), which is
close to the action spectrum maximum for CPD induction in vitro39. Action spectroscopy shows that production of CPD at 300–310 nm is three orders of magnitude lower than at 254 nm40. Figure 6 shows that 254 nm
induced high levels of CPD as well as oxidized purines. Although UVC-induced 8-oxoGua has been previously
reported41–43 there is little literature on UVC-induced cellular oxidative stress. One report has suggested that
UVC-induced 8-oxoGua formation is via 1O230, although it is not clear how this would occur, and the involvement
of guanine radical cations are perhaps a more likely mechanism44. Pre-UVC incubation with vitamin E significantly protected against the formation of oxidized purines but not against CPD (Fig. 6). As can be seen in Fig. 7,
vitamin E absorption at 254 and ~300 nm is similar, but higher than at longer wavelengths in the UVAI source.
Thus, one might expect a comparable or better sunscreening effect for CPD at 254 nm than with UVAI. The lack
of such an effect for CPD suggests that protection against the formation of oxidized purines is via mechanisms
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Spectral Region

Wavelength (nm)

UVA

321–400

% of total irradiance
99.8

87.5

UVAI

340–400

97.5

78.4

UVAII

321–340

2.3

9.1

UVB (CIE)*

281–315

0.1

10.4
12.7

UVB

281–320

0.2

UVC

200–280

0.0

Total UVR

200–400

100

% EEE

0
100

Table 2. Spectroradiometric distribution of the emission spectrum (see Fig. 1) of the UVAspot (measured
through the plastic lid of a 6-well plate used in the experiments), and their respective erythemally effective
energies (EEE), obtained by multiplying with the CIE action spectrum for erythema25. This shows that the
majority of the EEE was in the UVAI region. *Official CIE definition of UVB, but a cut-off at 320 nm is used in
dermatology research.
other than sunscreening. Furthermore, the action spectrum for 8-oxoGua formation shows a peak in the UVAI
(λmax = 365 nm) region40, although UVB may also induce this lesion7. We recognize that the very small UVB
content (0.1%) of our UVAI source (Table 2) may have caused a disproportionally large number of CPD45 but the
complete lack of effect of vitamin E on UVC-induced CPD supports a different mechanism for UVAI-induced
CPD.
CPDs are formed mainly via direct photon absorption by DNA in the UVC and UVB regions. DNA shows some
direct UVA absorption46 which is well established to result in CPD formation in vitro and in vivo, in cellular47–51,
and naked DNA4,51–56, and is likely to represent the main pathway for the majority of CPD formation, with UVAI
inducing CPD at a ratio of 87:9:4 for T <  > T, T <  > C and C <  > C, respectively50. However, UVA-induced CPD
may also be formed by photosensitization, and chemiexcitation reactions in vitro as with carprofen57 and melanin13. In this case the photosensitizer is converted to its triplet state, the energy of which, if high enough, is transferred to DNA to generate CPD58. Therefore, unidentified endogenous photosensitizers, which we have proposed
may possess structural similarities to pyridopsoralens59,60, might play a role in UVAI-induced CPD formation in
keratinocytes, especially in the more complex in vivo system. Our data suggest that vitamin E may quench the triplet state of a putative sensitizer. However, since similar levels of CPDs are induced by UVA in cellular and naked
DNA, this53,54,61 suggests that triplet energy transfer may be a minor process. Our results in cultured keratinocytes
indicate that there is an ~20% increase in CPD in the 1 h after removal from UVAI exposure.
UVA-induced lipofuscin in HaCaTs has been reported to be a photosensitizer for subsequent exposure (48 h
later) to visible radiation, which results in the formation of oxidatively induced damage to DNA62. Although we
did not measure visible radiation this was clearly present in our source (Fig. 7) especially in the violet region
(400–450 nm), which is reported to be very effective in the generation of 1O2 from lipofuscin63. On this basis, it
is possible that lipofuscin might be the unknown photosensitizer that is responsible for the ROS generation, and
formation of oxidized purines and ALS in our study. However, we lack data on the lipofuscin triplet energy level
so it is not possible to say whether or not lipofuscin could generate CPD by a sensitization reaction.
A comparison of the comet assay data from the pre- and post-UVA vitamin E incubation studies (Figs 2 and 5)
suggests some repair of oxidized purines and CPD during the 2.5 h post-UVA period. This was confirmed in
time-course studies with 5 J/cm2 (Fig. 3) that showed a t1/2 of about 4 h for both lesions (achieving a maximum at
1 h). This is similar to the t1/2 of ~4.5 h reported for UVA-induced CPD in HaCaTs in a recent publication from
our group64. However, the t1/2 for oxidized purines in the current study is faster than that of about 10 h in our previous study, in which we also showed that DNA repair kinetics were dependent on UVR spectrum. The times for
t1/2 are of course longer when using 0 h as a reference point. It should also be noted that very different UVA spectra
were used in the two studies. Our present time-course study demonstrates the formation of “dark DNA photolesions”, that have been recently reported for CPD in melanocytes13 but not for oxidatively-induced DNA lesions.
It is possible that vitamin E incubation post-UVAI exposure decreases CPD by enhancing their repair by
inhibiting ROS65 which, along with RNS, can damage/inhibit DNA repair enzymes and DNA polymerases (associated with both nucleotide excision repair (NER) and base excision repair (BER)66,67. This concept is supported
by studies that show that post-UVA treatment with vitamin D3 suppresses nitric oxide products resulting in
enhanced DNA repair; with a consequent reduction of CPD, immunosuppression and photocarcinogenesis68.
UVA induces oxidatively-generated crosslinking (through 1O2 production) between the subunits of the replication and repair protein, PCNA69. Furthermore, UVA-induced ROS are also known to activate several MAPKs70,
therefore, by affecting various downstream effectors, such as AP-1 and NFκB, they may alter DNA repair
responses, cell cycle arrest or apoptosis71. One study showed that vitamin E treatment post-UVR (broad spectrum) irradiation increased CPD repair in mouse skin in vivo and this result was correlated with decreased p53
protein levels72.
In the present study, we showed that vitamin E can inhibit UVAI-induced oxidizing species production and
induction of DNA damage, even when human keratinocytes are treated after irradiation. Whilst perhaps better
established for ROS-induced DNA damage, the important implication of this is that the process of CPD formation continues after irradiation has ended, implying a mechanism similar to that seen in melanocytes13,73. Several
questions remain about the chemistry behind the protection offered by vitamin E, and it is important to establish
whether similar protection levels can be demonstrated in human skin.

Scientific REPOrTS | (2018) 8:423 | DOI:10.1038/s41598-017-18924-4

7

www.nature.com/scientificreports/
An ideal sunscreen protects against UVR-induced, direct and indirect DNA damage, together with oxidative
stress, and erythema. Our data, and those from other groups4,54,74–76, support the addition of antioxidants to
sunscreens and after-sun preparations. Although relatively small, our demonstration of ‘dark’ CPD formation in
keratinocytes, in the absence of melanin, indicates that such preparations should also contain agents which are
both antioxidants and, for completeness, triplet state quenchers to decrease the formation of CPD in skin, which
continues even after sunlight exposure has ended.
Figure 3 shows the induction and repair of CPD. The delayed, secondary increase, peaking at 0.5–1 h after the
end of the UVR exposure, is very similar to that reported by Premi et al.13 for “dark” CPD. Whilst it is not possible to distinguish between ‘dark” CPD and the formation of those from direct UVR absorption (“light” CPD),
we speculate that CPD burden at time 0 h primarily represents the latter and that the peak at 0.5–1 h represents
the addition of “dark” to “light” CPD. We further speculate that there two overlapping CPD repair kinetics in
Fig. 3. The dashed line from 0 to 2.5 h, and continuing to the dotted line, mainly reflect the typical NER kinetics
of “light” CPD that is relatively slow with a half-life of 33.3 h in human epidermis in vivo77, but the rapid decline
from the peak to the 3 h timepoint suggests a different, faster repair process for the “dark” CPD, more akin to
the kinetics of the pyrimidine (6–4) pyrimidone photoproduct, with a half-life of 2.3 h in human epidermis in
vivo77. Although fast repair of CPD, under particular conditions, is not without precedent64. The reasons for these
differences remain to be elucidated. “light” and “dark” CPD may have different preferential nucleobases locations
or properties that differentially activate NER. For example, “dark” CPD are reported to include a higher ratio of
cytosine-containing (T <  > C and C <  > T), to thymine-thymine CPD13 and cytosine-containing CPD are more
rapidly repaired78. It is clear that “dark” CPD remain an intriguing phenomenon, and about which there is no
doubt much more for us to learn.

Materials and Methods

Cell culture and vitamin E treatment.

The HaCaT cell line (spontaneously immortalized keratinocytes)
was obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen, Paisley, UK) supplemented with 10% fetal calf serum
(Sigma-Aldrich, Poole, UK), 100 U/mL penicillin, and 100 μg/mL streptomycin (Invitrogen) and maintained at
37 °C in 95% air/5% CO2. Vitamin E (D-α-tocopherol; Sigma-Aldrich, Poole, UK) concentration was fixed at
0.1 mM for all experiments. The experimental procedure was designed to include two treatment protocols. Cells
were either treated with vitamin E for 24 h prior to UVA irradiation (pre-UVA treatment), or treated for 2.5 h after
irradiation under the incubation conditions described above. Various post-UVA incubation times were tested in
pilot studies and this time period was selected as the shortest period with a significant effect on both oxidized
purines and CPD (data not shown).

Irradiation and dosimetry. The UVAI source used was a UVASPOT (400/T, Dr K Hönle UVTechnologie,
Munich, Germany), the spectrum of which is shown in Fig. 7, and described in Table 2. The erythemal effective energy (EEE) was calculated using the erythemal action spectrum of the International Commission on
Illumination (CIE)79. Irradiance was determined with an International Light IL 442 A radiometer (Newbury
Port, MA, USA) with a UVA detector calibrated against the measurements made with a double-monochromator
spectroradiometer (Bentham Instruments, Reading, UK), which was calibrated against a UK national standard. Experiments to exclude any sunscreening effect of vitamin E were carried out with UVC (254 nm) using an
XX-15s UV Bench Lamp (UVP, Cambridge, UK).
Cell irradiation (in monolayers) was performed at 17 cm from the UVAI source, in PBS and a maximum
irradiation dose was fixed at 40 J/cm2. Comet assay experiments were accrued out with UVAI doses of 5 and 10 J/
cm2, while for the oxidizing species detection assay doses of 10, 20 and 40 J/cm2 were used. As the UVAI source
produced high levels of heat, a cooling platform was used at 6 °C that kept the cells at ~27 °C. Cells were kept on
ice after irradiation/treatment before any processing. Control (unirradiated) cell cultures were maintained under
the same conditions. UVC irradiation was performed at a distance of 25 cm from the lamp. Exposure was based
on time (10 and 20 s), and determined empirically.
Spectroscopy.

UVR absorbance of vitamin E (0.1 mg/mL in ethanol) was determined with a UV/Vis
Spectrophotometer (ATI Unicam, UK) between wavelengths 250–340 nm, to assess for a possible sunscreening
effect. An overlap between the emission spectrum of the UVAspot and the vitamin E absorption spectrum can be
observed in the 300–320 nm UVB region (Fig. 7).

Cell viability.

Twenty-four hours after UVAI exposure or vitamin E treatment, cell viability was determined
using both the trypan blue exclusion assay, and the MTT assay, to ensure the absence of any significant cytotoxicity. Trypan blue (Sigma-Aldrich, Poole, UK) (0.04% final concentration) was added to cell suspensions and
cells were counted in a haemacytometer. For the MTT assay, aliquots (20 μL) of MTT solution (10 mg/mL PBS)
were added to the cells, and incubated for 4 h at 37 °C. After this, 100 μL of lysis solution (0.04 M HCl in absolute
isopropanol) were added, and the cells shaken for approximately 10 min. The plates were subsequently read on a
plate reader at 550 nm.

Measurement of oxidizing species. We aimed to evaluate total intracellular ROS generation was detected
using 5-(and-6)-carboxy-2′,7′-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA; Invitrogen, Paisley,
UK). The reliability of this approach to measure intracellular H2O2 and ROS has been called into question,
and a number of caveats need to be considered. Specifically, oxidizing species other than ROS may also oxidize
carboxy-H2DCFDA to form a fluorescent product80 we acknowledge this caveat and use the term “oxidizing
species” accordingly.
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Figure 8. Representative images of (A) hOGG1-modified comet assay analysis of untreated cells; (B) hOGG1modified comet assay analysis of cells treated with 10 J/cm2 UVA; (C) hOGG1-modified comet assay analysis
of cells treated with 10 J/cm2 UVA, with post-irradiation with vitamin E; (D) T4endoV-modified comet assay
analysis of cells treated with UVC for 10 s; and (E) T4endoV-modified comet assay analysis of cells treated with
UVC for 10 s, after pre-incubation with vitamin E.

After UVAI exposure, 2 mL of 5 μM carboxy-H2DCFDA, diluted in PBS (containing 1 g/L glucose; Gibco)
were added to cell suspensions (PBS-only was added in control samples). Cells were incubated for 20 min, in the
dark, at 37 °C in a humidified incubator with 95% air/5% CO2. Plates were subsequently washed twice with PBS
to completely remove any dye not internalized by the cells.
For the pre-UVR vitamin E incubation experiments, cells were analyzed immediately following irradiation. Following trypsinisation, cells were centrifuged at 400 × g for 4 min at 4 °C and resuspended in 0.5 mL
of PBS + 0.1% (w/v) bovine serum albumin (BSA). Samples were then transferred to FACS tubes and analyzed with a Becton Dickinson FACSAria II instrument (BD Biosciences, San Jose, USA), using the FL1 channel (green fluorescence). The viable portion of the cell population was quantified by addition of 2.5 μg/mL
propidium iodide (PI) immediately before the analysis. Cells were then subjected to analysis by flow
cytometry.

Total glutathione measurement.

Intracellular concentrations of reduced glutathione (GSH) were determined using the GSH/GSSG kit (Calbiochem, La Jolla, CA,USA). Cell pellets were homogenized in 50 µL of cold
metaphosphoric acid (5% w/v) and resuspended in a total volume of 500 µL. The homogenate was centrifuged for
10 min (3,000 × g) at 4 °C, before 100 µL of supernatant was combined with the kit, and analysed using a UV-vis
spectrophotometer.

Measurement of DNA damage by the comet assay. DNA damage was assessed using the alkaline comet assay with specific protocol modifications, according to the type of damage investigated.
Oxidatively-induced DNA damage was measured using the human 8-oxoguanine DNA glycosylase 1
(hOGG1)-modified comet assay. hOGG1 recognizes 8-oxoGua, together with 2,6-diamino-4-hydroxy-5-f
ormamidopyrimidine 81, with minimal activity towards 4,6-diamino-5-formamidopyrimdine82. On this
basis, and as previously64, we have used the term “oxidised purines” to describe the damage recognized by the
hOGG1-modified comet assay. CPDs were assessed using the T4 endonuclease V (T4endoV)-modified comet
assay, as described elsewhere64. As we have noted previously64, there are no specific data concerning the preferential activity of T4endoV towards the potential combinations of pyrimidines in CPD. However, inferences can be
made from the ability of the enzyme to incise at all combinations of CPD, in plasmids and small bacteriophage
vectors, suggesting all are equal substrates.
Cells were counted before UVR exposure and distributed in the wells of a 9-well plate (~103 cells per well).
After irradiation, cells were collected and centrifuged at 400 × g for 4 min, at 4 °C. The supernatant was discarded
and pellets were kept on ice. Cells were mixed with 200 μL of low-melting point agarose and 75 μL of the gel was
quickly poured onto slides pre-coated with agarose. Coverslips were placed over the gels, and the slides were kept
on a tray on ice for 10 min to allow the agarose to set. Coverslips were then removed and the slides were placed
in a tank filled with lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM acid Tris, 1% sodium sarcosinate, pH 10, 1%
Triton X-100, and 10% dimethyl sulphoxide) for 16 h at 4 °C, in the dark.
After removing the lysis buffer, slides were washed with ice-cold ddH2O for 10 min (in the dark, to prevent
adventitious DNA damage). Slides were immersed twice in enzyme reaction buffer (40 mM Hepes, 0.1 M KCl,
0.5 mM EDTA, 0.2 mg/mL BSA, pH 8), for 5 min each, at room temperature. T4endoV (0.1 U/mL), or hOGG1
(3.2 U/mL), or enzyme reaction buffer alone, was added to each gel (both enzymes were purchased from New
England Biolabs, Hitchin, UK). Coverslips were placed on top of the gels to ensure equal distribution of the
enzymes, and slides were incubated at 37 °C in a humid atmosphere for 45 min. Slides were subsequently transferred to ice-cold electrophoresis buffer (NaOH 10 M, EDTA 200 mM, pH 13 in ddH2O) and incubated for 20 min
in the dark. Electrophoresis was then performed for 20 min at 25 V, 300 mA.
Finally, slides were rinsed with neutralization solution (0.4 M Trizma Base, pH 7.5; Sigma) for 20 min and
then washed with ddH2O for 10 min. Slides were allowed to dry at room temperature overnight. DNA was stained
using 1 mL of propidium iodide solution at 2.5 μg/mL in PBS per slide for 20 min. Slides were then washed with
ddH2O for 20 min. After drying, slides were examined at a magnification of 40×, using a Zeiss Axiophot epifluorescence microscope (Carl Zeiss, Germany) equipped with a green excitation filter. Images of the whole of each
slide were taken with a Nikon camera linked to the microscope. Fifty randomly selected cells per gel and three
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gels per condition were analysed (n = 150) using Comet Score (TriTek Corp., Summerduck, VA, USA). The percentage tail DNA (%DNA) was measured for each nucleoid body scored.
Representative images of comets are shown in Fig. 8.

Statistical analysis. All experiments were conducted in triplicate and values are presented as mean ± stand-

ard error of the mean (SEM). Comet assay values were compared for statistical significance with the Mann–
Whitney non-parametric test. For the measurement of oxidizing species, a Student’s t-test was used to determine
the degree of statistical significance between values from different experimental groups; results were plotted. All
analyses and graphs were performed using the GraphPad Prism 6 software (GraphPad Software Inc., San Diego,
CA, USA). Statistical significance was defined as p < 0.05.
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